NCT01366014 - A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

ARRY-371797, p38 inhibitor; oral

multiple dose, single schedule

DRUG

Oxycodone hydrochloride (HCl) extended release (ER), opioid agonist; oral

multiple dose, single schedule

DRUG

Placebo; oral

matching placebo

Trial Locations (13)

Pfizer Investigational Site, Duncansville

Pfizer Investigational Site, Fort Lauderdale

Pfizer Investigational Site, Pinellas Park

Pfizer Investigational Site, Sarasota

Pfizer Investigational Site, Olive Branch

Pfizer Investigational Site, Phoenix

Pfizer Investigational Site, Watertown

Pfizer Investigational Site, Charlotte

Pfizer Investigational Site, Raleigh

Pfizer Investigational Site, Winston-Salem

Pfizer Investigational Site, Austin

Pfizer Investigational Site, Salt Lake City

Pfizer Investigational Site, Kenosha